Vertex Pharmaceuticals had required 13F filings with the SEC and its stock traded on the Nasdaq exchange on September 8, 2026.
1 report, 1 independent
Updated Sep 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Vertex Pharmaceuticals had required 13F filings with the SEC and its stock traded on the Nasdaq exchange on September 8, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Vertex Pharmaceuticals
American pharmaceutical company
-
Securities and Exchange Commission
government agency of the Philippines
-
Nasdaq
American fully electronic stock exchange
Related events
- Morgan Stanley was involved in market activity on the electronic stock exchange, with filings received regarding this activity.
- Barrett & Company Inc. filed Form 13F with the Securities and Exchange Commission on October 24, 2026.
- The SEC requires institutional investors to file 13F reports for the JPMorgan International Research Enhanced Equity ETF.
- Medpace filed required documents with the Securities and Exchange Commission on August 15, 2026.
- Filings detail fund holdings for VGT with the Securities and Exchange Commission.